Abstract Purpose of Review The outbreak of the novel coronavirus disease 2019 (COVID-
19) has emerged to be the biggest global health threat worldwide, which has now infected …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and its clinical
manifestation, the coronavirus disease 2019 (COVID19) have rapidly spread across the …

The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since
being identified as a public health emergency of major international concern and has now …

ORIgINAl ARTIClE Wang, M. et al. KTE-X19 CAR T-cell therapy in relapsed or refractory
mantle-cell lymphoma. N. Engl. J. Med. 383, 1331–1342 (2020) 4.7% had severe clinical …

A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has spread across the world, prompting the World Health Organization to declare the …

Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide
threat and the major healthcare concern of the year 2020. Cancer research was directly …

In December 2019, a novel coronavirus called severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19) …

Abstract Coronavirus disease‐2019 (COVID‐19) has emerged as a novel infection which
has spread rapidly across the globe and currently presents a grave threat to the health of …

Numerous studies have been published regarding outcomes of cancer patients infected with
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus causing the …